Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Transcenta to Present Interim Safety and Efficacy Data of the TST001 and Chemotherapy Combination Expansion Cohort for Claudin18.2 Positive First Line Gastric Cancer at ESMO Congress 2022 2022-07-28 08:00
1